Sharma A, Apostolidou S, Burnell M, Campbell S, Habib M, Gentry-Maharaj A, et al. Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS). Ultrasound Obstet Gynecol 2012. 40: 338-44. doi: 10.1002/uog.12270
Van Calster B, Timmerman D, Valentin L, McIndoe A, Ghaem-Maghami S, Testa AC, et al. Triaging women with ovarian masses for surgery: observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis (IOTA) group protocol. BJOG 2012; 119: 662-71. doi: 10.1111/j.1471-0528.2012.03297.x
Thomassin-Naggara I, Poncelet E, Jalaguier-Coudray A, Guerra A, Fournier LS, Stojanovic S, et al. Ovarian-adnexal reporting data system magnetic resonance imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses. JAMA Netw Open 2020; 3: e1919896. doi: 10.1001/jamanetworkopen.2019.19896
Kataoka M, Kido A, Koyama T, Isoda H, Umeoka S, Tamai K, et al. MRI of the female pelvis at 3T compared to 1.5T: evaluation on high-resolution T2-weighted and HASTE images. J Magn Reson Imaging 2007; 25: 527-34. doi: 10.1002/jmri.20842
Léautaud A, Marcus C, Ben Salem D, Bouché O, Graesslin O, Hoeffel C. Pelvic MRI at 3.0 Tesla. J Radiol 2009; 90: 277-86. doi: 10.1016/s0221-0363(09)72506-5
Hussain SM, van den Bos IC, Oliveto JM, Martin DR. MR imaging of the female pelvis at 3T. Magn Reson Imaging Clin N Am 2006; 14: 537-44, vii. doi: 10.1016/j.mric.2007.01.008
Thomassin-Naggara I, Balvay D, Rockall A, Carette MF, Ballester M, Darai E, et al. Added value of assessing adnexal masses with advanced MRI techniques. Biomed Res Int 2015; 2015: 785206. doi: 10.1155/2015/785206
El-Wekil A, Mohammad S Abdullah MS, El-Kholy SS. The role of MRI in the differentiation between benign and malignant ovarian lesions. Menoufia Med J 2017; 32: 106-11. doi: 10.4103/mmj.mmj_548_17
Koc Z, Erbay G, Ulusan S, Seydaoglu G, Aka-Bolat F. Optimization of b value in diffusion-weighted MRI for characterization of benign and malignant gynecological lesions. J Magn Reson Imaging 2012; 35: 650-9. doi: 10.1002/ jmri.22871
Meinhold-Heerlein I, Fotopoulou C, Harter P, Kurzeder C, Mustea A, Wimberger P, et al. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications. Arch Gynecol Obstet 2016; 293: 695-700. doi: 10.1007/s00404-016-4035-8
Caruso PA, Marsh MR, Minkowitz S, Karten G. An intense clinicopathologic study of 305 teratomas of the ovary. Cancer 1971; 27: 343-8. doi: 10.1002/1097-0142(197102)27:2<;343::aid-cncr2820270215>3.0.co;2-b
Agostinho L, Horta M, Salvador JC, Cunha TM. Benign ovarian lesions with restricted diffusion. Radiol Bras 2019; 52: 106-11. doi: 10.1590/01003984.2018.0078
Feuerlein S, Pauls S, Juchems MS, Stuber T, Hoffmann MH, Brambs HJ, et al. Pitfalls in abdominal diffusion-weighted imaging: how predictive is restricted water diffusion for malignancy. AJR Am J Roentgenol 2009; 193: 1070-6. doi: 10.2214/AJR.08.2093
Dunn DP, Kelsey NR, Lee KS, Smith MP, Mortele KJ. Non-oncologic applications of diffusion-weighted imaging (DWI) in the genitourinary system. Abdom Imaging 2015; 40: 1645-54. doi: 10.1007/s00261-015-0471-3
Duarte AL, Dias JL, Cunha TM. Pitfalls of diffusion-weighted imaging of the female pelvis. Radiol Bras 2018; 51: 37-44. doi: 10.1590/01003984.2016.0208
Takeuchi M, Matsuzaki K, Nishitani H. Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses. J Comput Assist Tomogr 2010; 34: 173-6. doi: 10.1097/RCT.0b013e3181c2f0a2
Moyle PL, Kataoka MY, Nakai A, Takahata A, Reinhold C, Sala E. Nonovarian cystic lesions of the pelvis. Radiographics 2010; 30: 921-38. doi: 10.1148/rg.304095706
Kim MY, Rha SE, Oh SN, Jung SE, Lee YJ, Kim YS, et al. MR Imaging findings of hydrosalpinx: a comprehensive review. Radiographics 2009; 29: 495-507. doi: 10.1148/rg.292085070
Marko J, Marko KI, Pachigolla SL, Crothers BA, Mattu R, Wolfman DJ. Mucinous neoplasms of the ovary: radiologic-pathologic correlation Radiographics 2019; 39: 982-97. doi: 10.1148/rg.2019180221
Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST. CT and MR imaging of ovarian tumors with emphasis on differential diagnosis Radiographics 2002; 22: 1305-25. doi: 10.1148/rg.226025033
Cho SM, Byun JY, Rha SE, Jung SE, Park GS, Kim BK, et al. CT and MRI findings of cystadenofibromas of the ovary. Eur Radiol 2004; 14: 798-804. doi: 10.1007/s00330-003-2060-z
Tang YZ, Liyanage S, Narayanan P, Sahdev A, Sohaib A, Singh N, et al. The MRI features of histologically proven ovarian cystadenofibromas-an assessment of the morphological and enhancement patterns. Eur Radiol 2013; 23: 48-56. doi: 10.1007/s00330-012-2568-1
Siegelman ES, Outwater EK. Tissue characterization in the female pelvis by means of MR imaging. Radiology 1999; 212: 5-18. doi: 10.1148/radiology.212.1.r99jl455
Rockall A, Forstner R. Adnexal diseases. In: Hodler J, Kubik-Huch RA, von Schulthess GK, editors. Diseases of the abdomen and pelvis 2018-2021: diagnostic imaging. Cham (CH): IDKD Book; 2018. p. 75-84.
Imaoka I, Wada A, Kaji Y, Hayashi T, Hayashi M, Matsuo M, et al. Developing an MR imaging strategy for diagnosis of ovarian masses. Radiographics 2006; 26: 1431-48. doi: 10.1148/rg.265045206
Zhang H, Zhang GF, He ZY, Li ZY, Zhang GX. Prospective evaluation of 3T MRI findings for primary adnexal lesions and comparison with the final histological diagnosis. Arch Gynecol Obstet 2014; 289: 357-64. doi: 10.1007/s00404-013-2990-x
Hann LE, Lui DM, Shi W, Bach AM, Selland DL, Castiel M. Adnexal masses in women with breast cancer: US findings with clinical and histopathologic correlation Radiology 2000; 216: 242-7. doi: 10.1148/ radiology.216.1.r00jl15242
Yamashita Y, Hatanaka Y, Torashima M, Takahashi M, Miyazaki K, Okamura H. Characterization of sonographically indeterminate ovarian tumors with MR imaging. A logistic regression analysis. Acta Radiol 1997; 38: 572-7. doi: 10.1080/02841859709174389
Bent CL, Sahdev A, Rockall AG, Singh N, Sohaib SA, Reznek RH. MRI appearances of borderline ovarian tumours Clin Radiol 2009; 64: 430-8. doi: 10.1016/j.crad.2008.09.011
deSouza NM, O’Neill R, McIndoe GA, Dina R, Soutter WP. Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease. AJR Am J Roentgenol 2005; 184: 999-1003. doi: 10.2214/ ajr.184.3.01840999
Maggino T, Gadducci A, D’Addario V, Pecorelli S, Lissoni A, Stella M, et al., Prospective multicenter study on CA 125 in postmenopausal pelvic masses. Gynecol Oncol 1994; 54: 117-23. doi: 10.1006/gyno.1994.1179
Zhang H, Zhang GF, He ZY, Li ZY, Zhu M, Zhang GX. Evaluation of primary ad-nexal masses by 3T MRI: categorization with conventional MR imaging and diffusion-weighted imaging. J Ovarian Res 2012; 5: 33. doi: 10.1186/1757-2215-5-33